Edwards Lifesciences (EW)OFI Invest Asset Management reduced its stake -59K shares

458K

Shares reported · -59K vs prior quarter

0.36%

Disclosed portfolio weight

$36.5M

Reported value

Holdings as of

Jun 30, 2026

Filed

Jul 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 27, 2026CongressDisclosed purchase of EW — reported range $1,001 - $15,000
2. May 15, 2026Insider · 1 personInsiders: 2 sales (~$1.5M)
3. May 18, 2026InsiderOfficer sold ~$50K of EW shares in the open market
4. May 22, 2026InsiderOfficer sold ~$127K of EW shares in the open market
5. May 27, 2026InsiderOfficer sold ~$2M of EW shares in the open market
6. May 29, 2026InsiderOfficer sold ~$49K of EW shares in the open market
7. Jun 5, 2026FDAFDA device clearance: Fogarty Spring Clips, Handleless Clamps, and Clamp Inserts
8. Jun 11, 2026FDAFDA device clearance: Respiration Rate algorithm
9. Jun 17, 2026InsiderCEO sold ~$46K of EW shares in the open market
10. Jun 26, 2026FDAFDA device clearance: ECLIPTIS Left Atrial Appendage Exclusion System (ECS135); ECLIPTIS Left Atrial Appendage Exclusion System (ECS140); ECLIPTIS Left Atrial Appendage Exclusion Sy…
11. Jun 30, 2026InsiderOfficer sold ~$57K of EW shares in the open market
12. Jul 10, 2026InsiderOfficer sold ~$57K of EW shares in the open market

What came next

1. Jul 23, 2026Company filing · Form 8-K · ResultsReported its results
2. Jul 23, 2026Government · Federal Register noticeUnited States v. Edwards LifeSciences Corp. and Genesis MedTech Group Limited; Proposed Final Judgment and Competitive Impact Statement
3. Jul 27, 2026InsiderCEO sold ~$245K of EW shares in the open market
4. Jul 28, 2026InsiderOfficer sold ~$819K of EW shares in the open market
5. Jul 30, 2026InsiderOfficer sold ~$13K of EW shares in the open market
6. Aug 11, 2026InsiderOfficer sold ~$57K of EW shares in the open market
7. Aug 25, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“The Board of Directors of Edwards Lifesciences Corporation, a Delaware corporation (“Edwards” or the “Company”), has received notice from Donald E. Bobo, Jr., Corporate Vice President, Strategy and Corporate Development, of his decision to retire from the Company by mid-year 2027.”
8. Aug 26, 2026Insider · 2 peopleInsiders: 3 sales (~$3.0M)
9. Aug 28, 2026InsiderOfficer sold ~$238K of EW shares in the open market
10. Aug 31, 2026InsiderOfficer sold ~$50K of EW shares in the open market
11. Sep 11, 2026InsiderOfficer sold ~$54K of EW shares in the open market
12. Oct 8, 2026InsiderOfficer sold ~$53K of EW shares in the open market

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Edwards Lifesciences

For Edwards Lifesciences, OQRO holds 11 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 21 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EW page.

How this filing works

• SEC Form 13F

Other disclosures at Edwards Lifesciences

• SEC Form 4Oct 8, 2026
• SEC Form 4Sep 11, 2026
• SEC Form 4Aug 31, 2026
• SEC Form 4Aug 28, 2026
• SEC Form 4Aug 26, 2026
• SEC Form 4Aug 26, 2026

Everything OQRO holds on this company is on its EW page.